Previous Article | Next Article ![]()
Infection and Immunity, August 2000, p. 4574-4577, Vol. 68, No. 8
Department of Molecular Immunology, School of
Agriculture and Life Sciences, University of Tokyo, Tokyo
113,1 Laboratory of Immunology, Central
Institute for Experimental Animals, Kawasaki, Kanagawa
216,2 and 8th Laboratory, Kanagawa
Academy of Science and Technology, Kawasaki, Kanagawa
213,3 Japan, and Department of
Microbiology/Immunology, University of Health Science, Chicago
Medical School, North Chicago, Illinois 600644
Received 2 September 1999/Returned for modification 28 October
1999/Accepted 12 May 2000
One of the most characteristic clinical features in cutaneous
leishmaniasis is the development of nodules followed by ulcerations at
the site of infection. Leishmania amazonensis-infected mice show similar ulcerative lesions. Leishmania-infected severe
combined immunodeficiency (SCID) mice, however, have been shown
to develop nonulcerative nodules. In the present study, the
roles of T cells in ulceration were examined using SCID mice in cell
reconstitution experiments. After development of nonulcerative nodules,
SCID mice were inoculated with splenocytes from either
Leishmania-infected or naive immunocompetent mice,
resulting in ulceration in all mice. When naive splenocytes were
depleted of CD4+, CD8+, or B220+
cell populations and the remaining cells were injected into
Leishmania-infected SCID mice after the development of
nodules, only SCID mice inoculated with
splenocytes depleted of CD4+ cells did not show ulceration.
The evidence obtained in this study clearly
shows that the CD4+ cell population is indispensable for
ulceration in leishmaniasis lesions of SCID mice.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
CD4+ Cells Are Indispensable for Ulcer
Development in Murine Cutaneous Leishmaniasis

*
Corresponding author. Mailing address: Department of
Molecular Immunology, School of Agriculture and Life Sciences,
University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Phone: 81-3-5841-5197. Fax: 81-3-5841-8020. E-mail:
aysmatsu{at}mail.ecc.u-tokyo.ac.jp.
Present address: Molecular Immunogenetics and Vaccine Research
Section, Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|